GTM Strategy
-
Feasibility assessment and pricing strategy for the launch of diagnostic lab chains in India
- December 13, 2015
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Diagnostic Imaging, GTM Strategy, Market Entry Assessment, NPI Research, Pricing Research, Value Prop Assessment
No CommentsOverview: Market for Diagnostic labs in India In India, 70% of the treatment decisions are made based on lab results. Valued at over $7Bn, the diagnostics industry in India is largely unregulated and unorganized. While accreditation is optional, there are <800 medical labs that have been accredited by NABL. This represents roughly 1% of all -
New Product Introduction study for a wireless imaging sensor in US, Eu and Japan
- December 12, 2014
- Posted by: Team EMeRG
- Category: Africa, BY MEDICAL TECHNOLOGIES, Cardiovascular devices, Diagnostic Imaging, GTM Strategy, ICU equipment, Market Entry Assessment, Maternal & Infant Care, Nuclear Medicine Equipment, Operating Room devices, Patient Monitoring
“The biggest hurdle towards penetration is absence of Wi-Fi Direct capabilities in many medical devices. In the future, if it were to be allowed in the hospital system, authentication from the IT would become mandatory…” Overview: Market for Wi-Fi enabled Medical Devices Over the past decade, several med-tech companies have incorporated WLAN in their offerings -
Assessing reimbursement and pricing strategies for medical consumables and insulin delivery systems
- September 9, 2014
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Diabetes Management, GTM Strategy, Medical consumables, Pricing Research
Overview: Market for Insulin Delivery in India With >69Mn cases, diabetes represents significant disease burden in India. In Urban India, approximately 12% of adults live with diabetes, compared to only 7% in the United States and the United Kingdom. Indian insulin market is valued at over $230Mn with Novo Nordisk being the market leader. While rapid
- 1
- 2
RECOMMENDED ARTICLES
Contact us at EMeRG for your med-tech business intelligence needs in emerging markets